Alpha 2.0
Login Register
» Authors » M Phillip

M Phillip

Explore the profile of M Phillip including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 129
Citations 1464
Followers 0
Related Specialties
Endocrinology
Pediatrics
General Medicine
Top 10 Co-Authors
S Shalitin
L Lazar
G Gat-Yablonski
Y Segev
E Hershkovitz
L de Vries
A A Kowarski
D Landau
N Weintrob
A Pertzelan
Published In
J Pediatr Endocrinol Metab
Horm Res
J Clin Endocrinol Metab
Diabet Med
Isr J Med Sci
Affiliations
Soon will be listed here.
Recent Articles
1.
Response to letter of Dawson J. A, Brown A. W and Allison D. B: intervention for childhood obesity based on parents only or parents and child compared to follow-up alone
Yackobovitch-Gavan M, Wolf D, Nagelberg N, Poraz I, Shalitin S, Phillip M, et al.
Pediatr Obes . 2018 Aug; 13(11):658. PMID: 30160069
No abstract available.
2.
Intervention for childhood obesity based on parents only or parents and child compared with follow-up alone
Yackobovitch-Gavan M, Wolf Linhard D, Nagelberg N, Poraz I, Shalitin S, Phillip M, et al.
Pediatr Obes . 2018 Jan; 13(11):647-655. PMID: 29345113
Objectives: The study aims to assess the effects of family-based interventions targeted to parents only or to parents-and-child for the prevention and treatment of childhood obesity. Method: An open-label randomized...
3.
A novel heterozygous IGF-1 receptor mutation associated with hypoglycemia
Solomon-Zemler R, Basel-Vanagaite L, Steier D, Yakar S, Mel E, Phillip M, et al.
Endocr Connect . 2017 Jun; 6(6):395-403. PMID: 28649085
Mutation in the insulin-like growth factor-1 receptor () gene is a rare cause for intrauterine and postnatal growth disorders. Patients identified with mutations present with either normal or impaired glucose...
4.
Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome
Fuchs S, Gat-Yablonski G, Shtaif B, Lazar L, Phillip M, Lebenthal Y
J Endocrinol Invest . 2014 Oct; 38(4):399-406. PMID: 25344824
Context: Noonan syndrome (NS) is characterized by short stature and elevated risk of lymphedema. The mechanism underlying lymphedema may be mediated by vascular endothelial growth factors (VEGFs). Objective: To assess...
5.
A novel MKRN3 missense mutation causing familial precocious puberty
de Vries L, Gat-Yablonski G, Dror N, Singer A, Phillip M
Hum Reprod . 2014 Oct; 29(12):2838-43. PMID: 25316453
Central precocious puberty may be familial in about a quarter of the idiopathic cases. However, little is known about the genetic causes responsible for the disorder. In this report we...
6.
A family with a novel termination mutation in hepatic nuclear factor 1α in maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy
Demol S, Lebenthal Y, Bar-Meisels M, Phillip M, Gat-Yablonski G, Gozlan Y
Horm Res Paediatr . 2014 Mar; 81(4):280-4. PMID: 24642958
Background: Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes mellitus. Aims: To identify the genetic basis in a family with 3 generations of diabetes and to...
7.
Changes in weight and BMI following the diagnosis of type 1 diabetes in children and adolescents
de Vries L, Bar-Niv M, Lebenthal Y, Tenenbaum A, Shalitin S, Lazar L, et al.
Acta Diabetol . 2013 Oct; 51(3):395-402. PMID: 24158774
The aim of this study was to study weight and body mass index (BMI) before, at, and after diagnosis of type 1 diabetes (T1D) and to identify factors associated with...
8.
Using the Internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes
Shalitin S, Ben-Ari T, Yackobovitch-Gavan M, Tenenbaum A, Lebenthal Y, de Vries L, et al.
Acta Diabetol . 2013 Aug; 51(2):247-56. PMID: 23982170
The aim of this study is to assess the impact of the internet-based upload blood glucose monitoring and therapy management system (Carelink(®)) in patients with type 1 diabetes. Diabetic patients...
9.
Factors associated with diabetic ketoacidosis at onset of Type 1 diabetes in children and adolescents
de Vries L, Oren L, Lazar L, Lebenthal Y, Shalitin S, Phillip M
Diabet Med . 2013 Jun; 30(11):1360-6. PMID: 23758313
Aims: To identify risk factors for diabetic ketoacidosis at diagnosis of Type 1 diabetes in children and adolescents. Methods: In three time periods (1986-1987, 1996-1997 and 2006-2007) 75, 86 and...
10.
Decrease in frequency of ketoacidosis at diabetes onset over the past two decades - perspectives of a paediatric tertiary care centre
de Vries L, Oren L, Lebenthal Y, Shalitin S, Lazar L, Phillip M
Diabet Med . 2012 Apr; 29(8):e170-5. PMID: 22486389
Aims: To determine whether the frequency and severity of diabetic ketoacidosis and the clinical characteristics of children at diagnosis of Type 1 diabetes mellitus have changed over the past decades...